News by topic

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Sexually transmitted infections tests and treatment news

Show

From To
Sexually transmitted infections
Anti-herpes therapy reduces genital and plasma HIV viral load in MSM not taking HIV therapy

Daily treatment with the anti-herpes drug valaciclovir significantly reduced HIV viral load in both the blood and genital secretions of HIV/herpes simplex virus-2-infected men who

Published
13 November 2007
By
Michael Carter
Sexually transmitted infections
IAS: Aciclovir treatment doesn't significantly reduce HIV or HSV-2 shedding in genital secretions

HIV-positive women who are infected with herpes simplex virus-2 (HSV-2) experience only modest decreases in their HIV viral load in their genital secretions if they

Published
24 July 2007
By
Michael Carter
Sexually transmitted infections
IAS: Daily aciclovir doesn't reduce HIV risk in HSV-2-infected women - was poor adherence the reason?

The association between infection with HSV-2 (the virus that causes genital herpes) and the risk of HIV acquisition has been well-studied. A recent meta-analysis found

Published
23 July 2007
By
Michael Carter
Sexually transmitted infections
HIV-positive gay men in Amsterdam often incorrectly perceive the level of their viral load; implications for safer sex

The number of HIV-positive gay men reporting unprotected anal sex with casual partners increased significantly in Amsterdam between 2000 and 2003, according to a study

Published
09 September 2004
By
Michael Carter
Sexually transmitted infections
Taking HAART not associated with sexual risk taking, but belief that HAART makes HIV less infectious is, finds meta-analysis

HIV-positive individuals who are taking HAART do not have more unprotected sex, according to a meta-analysis of studies looking at the impact of HAART on

Published
12 July 2004
By
Michael Carter
Sexually transmitted infections
Rectal secretions from men who have sex with men contain more HIV than blood or semen

Levels of HIV RNA in rectal mucosa secretions from men who have sex with men (MSM) are higher than those in blood and semen, according

Published
16 June 2004
By
Christopher Gadd
Chemsex and recreational drug use
French IV drug users who report HAART side-effects have more risky sex

The perception of having adverse side-effects due to one’s HAART regime was the strongest single predictor of unsafe sexual behaviour among a cohort of French

Published
08 June 2004
By
Gus Cairns
Sexually transmitted infections
Americans change gonorrhoea treatment guidelines for gay men due to Cipro resistance

Ciprofloxacin (Cipro, and other antibiotics from the fluoroquinolone class, should no longer be used in the USA for the treatment of the sexually transmitted infection

Published
04 May 2004
By
Michael Carter
Sexually transmitted infections
Microbicides 2004 marks new wave of HIV prevention trials

The Microbicides 2004 meeting, which took place this week at London’s Hilton Metropole hotel, drew 800 participants from 53 countries for four days of intensive

Published
01 April 2004
By
Julian Meldrum
Sexually transmitted infections
Microbicides pose new challenges for design of research studies

As reported here on aidsmap, the big news at the Microbicides 2004 Conference in London was the imminent start of five large efficacy trials of

Published
01 April 2004
By
Gus Cairns
← Prev1...23456Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.